Advertisement

Topics

BioDelivery Sciences International Company Profile

17:12 EST 21st January 2019 | BioPortfolio

We are a specialty pharmaceutical company that is exploiting its licensed and proprietary patented drug delivery technologies to develop and commercialize, either on our own or in partnerships with third parties, clinically-significant new formulations of proven therapeutics.
Our development strategy focuses on the utilization of the FDA’s 505(b)(2) approval process to obtain more timely and efficient approval of new formulations of previously approved therapeutics which incorporate our licensed drug delivery technologies. Because the 505(b)(2) approval process is designed to address new formulations of previously approved drugs, we believe it has the potential to be more cost efficient and less time consuming than other FDA approval methods

Location

2501 Aerial Center Parkway, Suite 205
Morrisville
27560
United States of America

Contact

Phone: 919 653-5160
Fax: 919 653-5161
Email: bdsi-info@bdsinternational.com


News Articles [1050 Associated News Articles listed on BioPortfolio]

BioDelivery Sciences International (BDSI) Investor Presentation - Slideshow

BioDelivery Sciences Names Thomas Smith Chief Medical Officer

BioDelivery Sciences International (NASDAQ: BDSI) has appointed Thomas B. Smith to serve as chief medical officer. Smith comes to the Raleigh, NC, drug company from Charleston Laboratories in Jupiter,...

BioDelivery Sciences International, Inc.'s (BDSI) CEO Herm Cukier on Q2 2018 Results - Earnings Call Transcript

BioDelivery Sciences International's (BDSI) CEO Herm Cukier on Q3 2018 Results - Earnings Call Transcript

BioDelivery Sciences: Buy The Dip

BioDelivery Sciences Continues To Roll

Updated Investment Case On BioDelivery Sciences

BioDelivery Sciences Announces Changes to its Executive Leadership Team

James Vollins joins the Company in role of General Counsel, Chief Compliance Officer, and Corporate Secretary Ernest De Paolantonio, Chief Financial Officer announces plan to retire by mid-2019 Sc...

Drugs and Medications [95 Associated Drugs and Medications listed on BioPortfolio]

Mondoxyne nl 100mg [Oculus Innovative Sciences]

Monodoxyne NL 100mg

Mondoxyne [Oculus Innovative Sciences]

Mondoxyne NL 50mg

Isoxsuprine hydrochloride [BI-COASTAL PHARMA INTERNATIONAL LIMITED LIABILITY COMPANY]

Isoxsuprine Hydrochloride Tablets, USP

Deltasone [Oculus Innovative Sciences]

Deltasone 20mg prednisone tablets

Complera access [Gilead Sciences, Inc.]

These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA™ (emtricitabine, rilpivirine, tenofovir dis...

PubMed Articles [1260 Associated PubMed Articles listed on BioPortfolio]

Moving towards Universal Coverage of Direct-Acting Antiviral Therapies for Hepatitis C Infection in Canada: An Environmental Scan of Canadian Provinces and International Jurisdictions.

Direct-acting antivirals (DAAs) have become the standard treatment for patients with chronic hepatitis C infections because of their high cure rates and favourable side effect profiles; however, acces...

Académie des Sciences Prizes.

Visions for IAHSI, the International Academy of Health Sciences Informatics.

These visions for IAHSI, the newly founded International Academy of Health Sciences Informatics ("the Academy"), include the following principles, in order of descending priority: (1) The Academy shou...

Using the Multidimensional Prognostic Index to Predict Clinical Outcomes of Hospitalized Older Persons: a Prospective, Multicentre, International Study.

Multidimensional prognostic index (MPI) is useful as prognostic tool in hospitalized older patients, but our knowledge derived from retrospective studies. We therefore aimed to evaluate in a multi-cen...

Plasma Vitamin B12, Supplementation and Mortality.

Clinical Trials [1286 Associated Clinical Trials listed on BioPortfolio]

Study of BEMA™ Fentanyl in the Treatment of Breakthrough Pain in Cancer Subjects

The purpose of this study is to evaluate the efficacy of BEMA fentanyl at any dose in the management of breakthrough pain in cancer subjects on background opioid therapy. The standard of ...

Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimer´s Disease Patients

Cholinergic neurons in the basal forebrain project widely to the cerebral cortex and hippocampus. These neurons depend on nerve growth factor (NGF) from their target areas for survival. Im...

Study of the Safety of BEMA™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy

The purpose of this study is to evaluate the safety of BEMA fentanyl at any dose in the management of breakthrough pain in cancer subjects on background opioid therapy. The standard of car...

A Bio-equivalence Study of Sofosbuvir From Elbanovir 400 mg Film Coated Tablets ( Multi-Apex Pharma, Egypt) & Sovaldi 400 mg Film Coated Tablets (Gilead Sciences, United Kingdom)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Elbanovir 400 mg...

The International Polycap Study 3 (TIPS-3)

The randomized 2x2x2 factorial design placebo controlled trial will enroll 5000 participants (women 60 years or older and men 55 years or older) without known heart disease or prior stroke...

Companies [2407 Associated Companies listed on BioPortfolio]

NanoSphere Health Sciences Inc.

NanoSphere Health Sciences Inc., is a biotechnology firm specializing in the creation of the NanoSphere Delivery System™, a revolutionary platform using nanotechnology in the...

BioDelivery Sciences International, Inc.

BioDelivery Sciences (NASDAQ: BDSI) is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercia...

NanoSphere Health Sciences, Inc.

NanoSphere Health Sciences, Inc. is a biotechnology firm specializing in the creation of the patented NanoSphere Delivery System™, a revolutionary platform using nanotechnolo...

BioDelivery Sciences International

We are a specialty pharmaceutical company that is exploiting its licensed and proprietary patented drug delivery technologies to develop and commercialize, either on our own or in partnerships with th...

RxC International

RxC International is a life sciences management consulting firm specializing in corporate strategy, new product development, and commercialization. RxC International brings strate...

More Information about "BioDelivery Sciences International" on BioPortfolio

We have published hundreds of BioDelivery Sciences International news stories on BioPortfolio along with dozens of BioDelivery Sciences International Clinical Trials and PubMed Articles about BioDelivery Sciences International for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioDelivery Sciences International Companies in our database. You can also find out about relevant BioDelivery Sciences International Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record